S-4 Andarine

S-4 (Andarine): A Selective Androgen Receptor Modulator for Laboratory Research Use Only

Abstract

S-4, commonly known as Andarine, is a synthetic, nonsteroidal selective androgen receptor modulator (SARM) developed for experimental research involving androgen receptor signaling, tissue-selective anabolic activity, and prostate-related pathways. Although S-4 has demonstrated androgen receptor binding activity in preclinical studies, there is no reliable scientific evidence supporting its safety or efficacy for human performance enhancement or medical treatment. Its use is restricted exclusively to laboratory and research applications.

Chemical and Pharmacological Overview

Andarine (S-4) is classified as an early-generation SARM, engineered to selectively interact with androgen receptors in skeletal muscle and bone while limiting activity in androgen-sensitive tissues such as the prostate.

Due to its partial agonist properties, S-4 has been widely studied in laboratory environments to better understand androgen receptor modulation, anabolic signaling balance, and tissue-specific responses.

Key Characteristics

• Compound Name: S-4
• Common Name: Andarine
• Chemical Class: Nonsteroidal Selective Androgen Receptor Modulator (SARM)
• Primary Target: Androgen receptor (AR)
• Intended Use: Laboratory research only

Mechanism of Action (Research Context)

S-4 binds selectively to androgen receptors within target cells. Once bound, the ligand–receptor complex migrates to the nucleus and interacts with androgen response elements (AREs), influencing gene transcription involved in:

• Lean tissue maintenance
• Muscle protein turnover
• Nitrogen balance
• Prostate signaling modulation

Its partial agonist nature makes S-4 particularly useful for studying dose-dependent androgen receptor activation in controlled research settings.

Research Applications

In controlled in vitro and preclinical research environments, S-4 has been investigated for:

• Muscle wasting and atrophy models
• Prostate tissue and androgen signaling research
• Androgen receptor binding affinity studies
• Tissue-selective anabolic-to-androgenic activity comparisons
• Structure–activity relationship (SAR) analysis of early SARMs

⚠️ Important: Findings from laboratory and animal studies must not be extrapolated to human use.

Safety and Toxicological Considerations

The safety profile of S-4 in humans has not been established. Experimental observations have raised potential concerns related to:

• Endocrine suppression
• Visual pathway modulation (dose-dependent effects observed in research settings)
• Altered lipid metabolism
• Hormonal imbalance with extended exposure

As a result, S-4 should only be handled by qualified researchers following appropriate laboratory safety and chemical handling protocols.

Regulatory and Legal Status

• United States:
  SARMs, including S-4 (Andarine), are prohibited from inclusion in dietary supplements. Products marketed for human consumption containing S-4 may violate federal regulations.
• Anti-Doping Regulations:
  S-4 is banned by:
  • World Anti-Doping Agency (WADA)
  • National Collegiate Athletic Association (NCAA)
• Detection:
  S-4 and its metabolites are detectable in urine, making it incompatible with any drug-tested environment.

Ethical and Compliance Notice

S-4 (Andarine) is not approved for:

• Human consumption
• Veterinary use
• Medical or therapeutic treatment
• Nutritional supplementation

All experimental use must comply with institutional research standards, regulatory frameworks, and ethical guidelines.

S-4 (Andarine) remains an important compound in the scientific exploration of selective androgen receptor modulation. However, due to regulatory restrictions, incomplete safety data, and anti-doping prohibitions, its application is strictly limited to laboratory research use only.

⚠️ Disclaimer

For laboratory research use only.
Not for human or animal consumption.
Not approved as a drug, supplement, or therapeutic agent.